Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.

PubWeight™: 1.92‹?› | Rank: Top 3%

🔗 View Article (PMID 2984080)

Published in Gastroenterology on May 01, 1985

Authors

C Niederau, L D Ferrell, J H Grendell

Associated clinical trials:

Secretin for Acute Pancreatitis (SNAP) | NCT03686618

Articles citing this

Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest (2000) 3.47

A better model of acute pancreatitis for evaluating therapy. Ann Surg (1992) 2.81

Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Natl Acad Sci U S A (2000) 2.34

Repetitive self-limited acute pancreatitis induces pancreatic fibrogenesis in the mouse. Dig Dis Sci (2000) 1.55

Zymophagy, a novel selective autophagy pathway mediated by VMP1-USP9x-p62, prevents pancreatic cell death. J Biol Chem (2010) 1.39

Intracellular vacuoles in experimental acute pancreatitis in rats and mice are an acidified compartment. J Clin Invest (1988) 1.30

Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc Natl Acad Sci U S A (1989) 1.29

Review of experimental animal models of acute pancreatitis. HPB (Oxford) (2006) 1.24

Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. J Clin Invest (1986) 1.23

Evidence for a role of oxygen derived free radicals in the pathogenesis of caerulein induced acute pancreatitis in rats. Gut (1988) 1.22

Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut (1998) 1.16

Animal models for investigating chronic pancreatitis. Fibrogenesis Tissue Repair (2011) 1.14

Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion. Gut (2006) 1.13

Quantitative organellar proteomics analysis of rough endoplasmic reticulum from normal and acute pancreatitis rat pancreas. J Proteome Res (2010) 1.11

Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol (2008) 1.04

Suppression of transforming growth factor beta signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations. Gut (2006) 1.03

Protease activation during in vivo pancreatitis is dependent on calcineurin activation. Am J Physiol Gastrointest Liver Physiol (2009) 0.99

The use of animal models to study bacterial translocation during acute pancreatitis. J Gastrointest Surg (2007) 0.97

Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Curr Top Med Chem (2007) 0.95

Dantrolene mitigates caerulein-induced pancreatitis in vivo in mice. Am J Physiol Gastrointest Liver Physiol (2010) 0.93

Glutathione monoethyl ester ameliorates caerulein-induced pancreatitis in the mouse. J Clin Invest (1992) 0.91

Allopurinol attenuates caerulein induced acute pancreatitis in the rat. Gut (1988) 0.90

Preventive action of curcumin in experimental acute pancreatitis in mouse. Indian J Med Res (2011) 0.89

Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS Genet (2015) 0.88

Noggin attenuates cerulein-induced acute pancreatitis and impaired autophagy. Pancreas (2013) 0.87

Characterisation of a transgenic mouse expressing R122H human cationic trypsinogen. BMC Gastroenterol (2006) 0.86

5-lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein. Immunology (2003) 0.84

Dynamic imaging of pancreatic nuclear factor κB (NF-κB) activation in live mice using adeno-associated virus (AAV) infusion and bioluminescence. J Biol Chem (2015) 0.84

Caerulein-induced acute pancreatitis in mice that constitutively overexpress Reg/PAP genes. BMC Gastroenterol (2006) 0.83

Animal models of pancreatitis: can it be translated to human pain study? World J Gastroenterol (2013) 0.82

Pharmacologic therapy for acute pancreatitis. World J Gastroenterol (2014) 0.81

Duration of injury correlates with necrosis in caerulein-induced experimental acute pancreatitis: implications for pathophysiology. Int J Exp Pathol (2014) 0.81

Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice. HPB (Oxford) (2010) 0.80

Age-dependent effects of UCP2 deficiency on experimental acute pancreatitis in mice. PLoS One (2014) 0.80

An exploratory study on the development of an animal model of acute pancreatitis following nicotine exposure. Tob Induc Dis (2003) 0.80

Protective action of luminal bile salts in necrotizing acute pancreatitis in mice. J Clin Invest (1990) 0.80

IP3 receptor type 2 deficiency is associated with a secretory defect in the pancreatic acinar cell and an accumulation of zymogen granules. PLoS One (2012) 0.79

CXCR2 inhibition suppresses acute and chronic pancreatic inflammation. J Pathol (2015) 0.79

Blockade of Multidrug Resistance-Associated Proteins Aggravates Acute Pancreatitis and Blunts Atrial Natriuretic Factor's Beneficial Effect in Rats: Role of MRP4 (ABCC4). Mol Med (2015) 0.76

Suppression of acute pancreatitis by L-lysine in mice. BMC Complement Altern Med (2015) 0.76

The mtDNA nt7778 G/T polymorphism augments formation of lymphocytic foci but does not aggravate cerulein-induced acute pancreatitis in mice. PLoS One (2014) 0.76

Changes in gene expression of tumor necrosis factor alpha and interleukin 6 in a canine model of caerulein-induced pancreatitis. Can J Vet Res (2016) 0.75

Anterior Gradient 2 (AGR2) Induced Epidermal Growth Factor Receptor (EGFR) Signaling Is Essential for Murine Pancreatitis-Associated Tissue Regeneration. PLoS One (2016) 0.75

Receptor strategies in pancreatitis. Yale J Biol Med (1993) 0.75

Quantitative Evaluation and Selection of Reference Genes for Quantitative RT-PCR in Mouse Acute Pancreatitis. Biomed Res Int (2016) 0.75

Clusterin and Pycr1 alterations associate with strain and model differences in susceptibility to experimental pancreatitis. Biochem Biophys Res Commun (2016) 0.75

Cholecystokinin antagonist L364,718 induces alterations in acinar cells that prevent improvement of acute pancreatitis induced by obstruction. Dig Dis Sci (2002) 0.75

Animal models of gastrointestinal and liver diseases. Animal models of acute and chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol (2016) 0.75

Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects. Int J Mol Med (2016) 0.75

Loss of Ifnar1 in Pancreatic Acinar Cells Ameliorates the Disease Course of Acute Pancreatitis. PLoS One (2015) 0.75

Experimental Models in Syrian Golden Hamster Replicate Human Acute Pancreatitis. Sci Rep (2016) 0.75

Bile induced acute oedematous pancreatitis in rats: non-parallel changes in pancreatic morphology and amylase release in vitro. Gut (1994) 0.75

Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor. Int J Obes Suppl (2016) 0.75

Caerulein or taurocholate induced enzymatic and histologic alterations in the isolated perfused rat pancreas. Langenbecks Arch Surg (2008) 0.75

Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis. J Neuroimmune Pharmacol (2017) 0.75

Articles by these authors

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet (1998) 9.78

Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med (1991) 3.73

Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73

Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A (1995) 2.80

Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol (2001) 2.72

Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53

Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology (1994) 2.30

Influence of ductal pressure and infusates on activity and subcellular distribution of lysosomal enzymes in the rat pancreas. Gastroenterology (1995) 2.22

Toxicity of compound A in rats. Effect of increasing duration of administration. Anesthesiology (1994) 2.12

[Demonstration of HFE polymorphism in German patients with hereditary hemochromatosis]. Dtsch Med Wochenschr (1999) 2.03

Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology (1990) 2.02

Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology (1997) 1.66

Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol (1997) 1.65

Hydrocolonic ultrasonography in the detection of colonic polyps and tumors. N Engl J Med (1994) 1.53

Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas (1992) 1.53

Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg (1996) 1.51

Fatal acute hepatic necrosis due to fluconazole. Am J Med (1994) 1.49

Mesenteric venous thrombosis. Gastroenterology (1982) 1.47

Premature trypsinogen activation during cerulein pancreatitis in rats occurs inside pancreatic acinar cells. Pancreas (1998) 1.45

Effects of bile and pancreatic digestive enzymes on permeability of the pancreatic duct system in rabbits. Pancreas (1993) 1.42

[The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases]. Z Gastroenterol (1997) 1.41

Lipopeliosis. An immunohistochemical and clinicopathologic study of five cases. Am J Surg Pathol (1994) 1.39

Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation (1993) 1.38

Endoscopic sclerotherapy versus portacaval shunt in patient with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up. N Engl J Med (1987) 1.35

Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol (1999) 1.35

Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med (1984) 1.31

Codistribution of TAP and the granule membrane protein GRAMP-92 in rat caerulein-induced pancreatitis. Am J Physiol (1998) 1.31

Intracellular vacuoles in experimental acute pancreatitis in rats and mice are an acidified compartment. J Clin Invest (1988) 1.30

Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel. Dig Dis Sci (1995) 1.29

Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Hepatogastroenterology (1997) 1.25

Carotid plaque hemorrhage. Its role in production of cerebral ischemia. Arch Surg (1982) 1.24

Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. J Clin Invest (1986) 1.23

Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia (1984) 1.23

Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology (2000) 1.22

Oxidative stress in acute pancreatitis. Hepatogastroenterology (2000) 1.20

Diagnosis of chronic pancreatitis. Gastroenterology (1985) 1.18

Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicenter trial. Digestion (1992) 1.16

Sonographic measurements of the normal liver, spleen, pancreas, and portal vein. Radiology (1983) 1.13

Carotid plaque histology using real-time ultrasonography. Clinical and therapeutic implications. Am J Surg (1983) 1.11

Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Gut (1987) 1.11

Middle aortic syndrome. Effectiveness and durability of complex arterial revascularization techniques. Ann Surg (1986) 1.10

Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor. Gastroenterology (1988) 1.09

Cancer-associated alterations of blood group antigen expression in the human pancreas. J Natl Cancer Inst (1987) 1.08

Angiomyolipoma of the liver in fine-needle aspiration biopsies: its distinction from hepatocellular carcinoma. Cancer (1999) 1.06

Hereditary chondrocalcinosis in a Mexican-American family. Arthritis Rheum (1983) 1.06

Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts? J Clin Pathol (2009) 1.05

Intrapancreatic zymogen activation and levels of ATP and glutathione during caerulein pancreatitis in rats. Am J Physiol (1995) 1.04

Effects of antioxidants and free radical scavengers in three different models of acute pancreatitis. Pancreas (1992) 1.03

Pathogenesis of genetic haemochromatosis. Eur J Clin Invest (1993) 1.02

Food, duodenal extracts, and enzyme secretion by the pancreas. Am J Physiol (1982) 1.02

Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease. Liver (1999) 1.00

Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results. Skeletal Radiol (2001) 1.00

Detection of Crohn's disease by ultrasound. Gastroenterology (1982) 0.99

Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization. Hum Pathol (2000) 0.99

Cholestatic hepatitis C in liver allografts. Liver Transpl Surg (1998) 0.97

Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology (1996) 0.97

Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation. J Hepatol (1999) 0.96

Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial. J Viral Hepat (2007) 0.96

Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol (1994) 0.95

Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol (1996) 0.95

Cytomegalovirus-associated acute pancreatic disease in patients with acquired immunodeficiency syndrome. Report of two patients. Gastroenterology (1990) 0.95

Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. Virology (2000) 0.95

Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free Radic Res (1997) 0.94

Survival and causes of death in hemochromatosis. Observations in 163 patients. Ann N Y Acad Sci (1988) 0.93

Impact of preshunt liver histology on survival following portasystemic shunt surgery for bleeding esophageal varices. Dig Dis Sci (1983) 0.93

[Epidemiology of chronic hepatitis C in Germany--an analysis of 10,326 patients in hepatitis centres and outpatient units]. Z Gastroenterol (2008) 0.93

Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation. AJR Am J Roentgenol (1986) 0.93

New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues. Am J Physiol (1986) 0.92

Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial. Ann Intern Med (1991) 0.92

Comparison of the extrahepatic bile duct size measured by ultrasound and by different radiographic methods. Gastroenterology (1984) 0.92

[Diagnosis of and therapy for hepatocellular carcinoma]. Z Gastroenterol (2013) 0.91

Glutathione monoethyl ester ameliorates caerulein-induced pancreatitis in the mouse. J Clin Invest (1992) 0.91

Growing pancreatic acinar cells (postpancreatitis and fetal) express a ductal antigen. Pancreas (1990) 0.91

Endoscopic laser treatment for gastrointestinal vascular ectasias. Ann Intern Med (1986) 0.90

[Exocrine pancreatic function test by N-benzoyl-L-tyrosyl-p-aminobenzoic acid (author's transl)]. Z Gastroenterol (1979) 0.90

Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients. J Vasc Surg (1992) 0.90

Menadione induces both necrosis and apoptosis in rat pancreatic acinar AR4-2J cells. Free Radic Biol Med (1997) 0.89

Transient ischaemic attacks: the static and dynamic morphology of the carotid artery bifurcation. Br J Surg (1982) 0.89

Treatment results of chronic hepatitis C genotype 5 and 6 infections in Germany. Z Gastroenterol (2012) 0.89

Abnormalities in estrogen, androgen, and insulin metabolism in idiopathic hemochromatosis. Ann N Y Acad Sci (1988) 0.89

Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg (1995) 0.88

Iron uptake by rat duodenal microvillous membrane vesicles: evidence for a carrier mediated transport system. Eur J Clin Invest (1987) 0.88

Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation. Hepatology (1996) 0.88

Intragraft cytokine profile during human liver allograft rejection. Transplantation (1992) 0.88

Intracellular events in the pathogenesis of acute pancreatitis. Pancreas (1991) 0.87

Toxicity of sevoflurane in rats. Anesth Analg (1987) 0.87

Rat pancreatic zymogen granules. An actively acidified compartment. Gastroenterology (1986) 0.87